Stock Market Reviews

Read and share opinions on XRTX (XORTX Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• XORTX Announces Closing of US$1.1 Million Registered Direct Offering
  Oct 29, 2025
• XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering
  Oct 21, 2025
• XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
  Oct 21, 2025
• XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
  Oct 21, 2025
• XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
  Oct 20, 2025
• XORTX Therapeutics Jumps 45% on US$3 Million Deal to Buy Renal Program From Vectus Biosystems
  Oct 17, 2025
• XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
  Oct 17, 2025
• Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
  Sep 4, 2025
• XORTX Therapeutics Edging Up In US Premarket As Initiates IND Preparation for XORLO in Gout Program
  Sep 3, 2025
• XORTX Initiates IND Preparation for XORLO™ in Gout Program
  Sep 3, 2025
• XORTX Completes USD $114,500 Private Placement
  Aug 8, 2025
• XORTX Provides Corporate Update and Planned Activities for 2025 / 2026
  Aug 7, 2025
• XORTX Announces USD $114,500 Private Placement
  Jul 31, 2025
• XORTX Completes Non-Brokered Private Placement of Units
  Jul 22, 2025
• XORTX Announces USD $925,000 Private Placement
  Jun 26, 2025
• XORTX Announces USD $3 Million Offering
  May 19, 2025
• XORTX Provides Update on FDA Type B Meeting Request
  Apr 30, 2025
• XORTX Announces Grant of European Patent
  Apr 28, 2025
• XORTX Announces Update for Discussion with the FDA
  Mar 19, 2025